EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 244 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2019. The put-call ratio across all filers is 8.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $457,000 | +17.5% | 8,738 | +8.4% | 0.01% | +10.0% |
| Q2 2019 | $389,000 | -3.2% | 8,058 | +1.3% | 0.01% | 0.0% |
| Q1 2019 | $402,000 | -14.8% | 7,956 | 0.0% | 0.01% | -23.1% |
| Q4 2018 | $472,000 | -9.4% | 7,956 | +0.4% | 0.01% | +8.3% |
| Q3 2018 | $521,000 | +30.9% | 7,922 | +0.4% | 0.01% | +20.0% |
| Q2 2018 | $398,000 | -4.1% | 7,888 | 0.0% | 0.01% | -9.1% |
| Q1 2018 | $415,000 | +29.3% | 7,888 | +14.3% | 0.01% | +22.2% |
| Q4 2017 | $321,000 | +39.0% | 6,902 | +20.8% | 0.01% | +28.6% |
| Q3 2017 | $231,000 | +66.2% | 5,712 | +38.8% | 0.01% | +75.0% |
| Q2 2017 | $139,000 | +135.6% | 4,114 | +101.7% | 0.00% | +100.0% |
| Q1 2017 | $59,000 | -55.3% | 2,040 | -49.2% | 0.00% | -50.0% |
| Q4 2016 | $132,000 | – | 4,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
| GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
| Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
| ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
| RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
| NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
| Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |